Status:
UNKNOWN
Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis
Lead Sponsor:
Zagazig University
Conditions:
Bacterial Vaginosis Treatment
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
Brief Summary
Vaginal Clindamycin Cream Plus Vaginal probiotic for treatment of Bacterial Vaginosis
Detailed Description
Vaginal Clindamycin Cream was used initially for treatment of Bacterial Vaginosis followed by Vaginal probiotic either in cnotinous or interrupted manner, then assessment of the results of treatment a...
Eligibility Criteria
Inclusion
- more than 18 years
- has recurrent Bacterial Vaginosis
Exclusion
- pregnancy
- use of other antmicrobial
- not provide informed consent
Key Trial Info
Start Date :
August 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03234517
Start Date
August 1 2016
End Date
August 1 2018
Last Update
August 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig University
Zagazig, Egypt